论文部分内容阅读
目的:观察口服孟鲁司特钠加气雾吸入普米克令舒预防儿童喘息性支气管肺炎及支气管哮喘的疗效。方法:对临床25例儿童喘息性支气管肺炎及支气管哮喘加用孟鲁司特钠口服与对照组25例进行比较。结果:治疗组总有效率92%(23/25),对照组总有效率80%(20/25)。结论:孟鲁司特钠预防儿童喘息性支气管肺炎及支气管哮喘疗效显著,未见明显副作用发生。
Objective: To observe the efficacy of oral montelukast sodium inhalation of pulmicort respules in preventing children asthmatic bronchial pneumonia and bronchial asthma. Methods: Twenty-five children with asthmatic bronchopneumonia and bronchial asthma were enrolled in this study. 25 patients were treated with montelukast sodium orally and the control group. Results: The total effective rate was 92% (23/25) in the treatment group and 80% (20/25) in the control group. Conclusion: Montelukast prevent children asthmatic bronchopneumonia and bronchial asthma significantly, no obvious side effects.